Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$373K Hold
1,481
0.12% 116
2026
Q1
$322K Sell
1,481
-170
-10% -$37.7K 0.12% 120
2025
Q4
$377K Hold
1,651
0.15% 112
2025
Q3
$382K Hold
1,651
0.15% 107
2025
Q2
$306K Buy
1,651
+79
+5% +$14.7K 0.13% 117
2025
Q1
$329K Sell
1,572
-75
-5% -$14.6K 0.16% 106
2024
Q4
$293K Hold
1,647
0.14% 110
2024
Q3
$325K Sell
1,647
-39
-2% -$7.28K 0.15% 106
2024
Q2
$289K Sell
1,686
-6
-0.4% -$994 0.14% 103
2024
Q1
$308K Hold
1,692
0.16% 106
2023
Q4
$262K Buy
1,692
+107
+7% +$15.6K 0.16% 104
2023
Q3
$236K Buy
1,585
+235
+17% +$34.5K 0.16% 110
2023
Q2
$182K Sell
1,350
-870
-39% -$128K 0.12% 128
2023
Q1
$354K Hold
2,220
0.23% 101
2022
Q4
$359K Buy
+2,220
New +$340K 0.21% 106

Other funds holding ABBV

Centennial Bank's ABBV Position: Q2 2026 in Review

Centennial Bank held its AbbVie (ABBV) position steady in Q2 2026 at 1,481 shares worth $373K. The position accounts for 0.12% of the portfolio, ranked #116.

Centennial Bank first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $382K in Q3 2025. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Centennial Bank held 1,481 shares of AbbVie worth $373K as of Q2 2026.
  • Centennial Bank left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.12% of Centennial Bank's portfolio in Q2 2026, its #116 holding.
  • Centennial Bank first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • Centennial Bank's AbbVie position peaked at $382K in Q3 2025.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Centennial Bank's 13F filing for Q2 2026, filed 10 Aug 2026.